Clinical Trials

LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures

PF-06741086 Multiple Dose Study in Severe Hemophilia

Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) Scale

PROPACT: Retrospective Prophylaxis Patient Case Collection

Prophylaxis Regimen for Hemophilia A Patients

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra

Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia

The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs

ATHNdataset Registry

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

Liver Function Abnormalities in Patients With Acute Heart Failure

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products

A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM

Osteoporosis and MRI Study in Hemophilia

Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders

A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients

Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders